NASDAQ:NOVOB.CO 1 February 2026

Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000

Novo Nordisk Class B shares closed at 369.6 Danish crowns on Friday, down 0.8 crown, as investors awaited the company’s 2025 financial statement set for Feb. 4. U.S. prescriptions for the new Wegovy pill surged to 26,109 in the week ending Jan. 23, up sharply from its launch. Leadership changes in China and rising competition from AstraZeneca add pressure ahead of earnings.

1 February 2026

Earnings Reports·NASDAQ:NOVOB.CO·Pharmaceuticals·Stock Market

Broadcom Set to Surge 91% and Join $3 Trillion Tech Titans Club
March 15, 2026, 7:11 AM EDT. Broadcom's (AVGO) market cap stands at $1.6 trillion, with potential to soar 91% to join Nvidia, Apple, Alphabet, and Microsoft in the $3 trillion club. The semiconductor giant benefits from rising demand for data center products supporting artificial intelligence (AI), especially its Application-Specific Integrated Circuits (ASICs). These custom chips offer a cost-efficient alternative to GPUs, crucial for AI workloads. Broadcom's recent financials reflect this growth: record fiscal Q1 revenue of $19.3 billion, up 29% year-over-year, and guidance for nearly 47% revenue jump in Q2. Analysts forecast close to $105 billion revenue for fiscal 2026, positioning Broadcom on a trajectory to $3 trillion valuation if it reaches $200 billion in revenue with consistent price-to-sales multiples. The company's critical role in AI and data center expansion underpins bullish investor sentiment.